Gary Guthart on trade policy
From Intuitive Surgical Inc ($ISRG) Q1 2025 Earnings Call · · Castify Earnings Call
“Given the dynamic changes in trade policy, I'd like to describe our principles for navigating the current environment rather than detailing any particular scenario. Our first priority is to assure supply of our products to our customers globally. We have spent years becoming a trusted provider of great products and services and our first commitment is to maintaining this status for those who depend upon us. We believe that high quality minimally invasive care at industrial scale will remain a global need regardless of trade policy and our long-term opportunity remains robust. We will continue to manage the business for the long term and invest towards improvement in the quintuple lane. Given potential changes in our costs and our customers costs across their enterprise, we do not plan reflexive changes to our pricing in the dynamic near-term environment.”
On , Gary Guthart, Executive Chair at Intuitive Surgical, Inc, spoke about trade policy during Intuitive Surgical Inc ($ISRG) Q1 2025 Earnings Call on Castify Earnings Call.
About Gary Guthart
During Intuitive Surgical’s Q1 2025 earnings call on April 1, 2025, Gary Guthart addressed the impact of trade policy changes on the company. He stated that the company’s first priority is to assure product supply to customers globally and that it does not plan “reflexive changes to our pricing in the dynamic near-term environment.” He added that a second priority will be to optimize production costs and rebalance product flows within the existing manufacturing and supply chain footprint as policies stabilize. Guthart attributed roughly half of a 170-basis-point impact in 2025 to U.S.-China trade in both directions and about 40% to imports into the U.S. from China, Mexico, and Canada. Guthart said the company is “perceived as part of the solution, not part of the problem” and that customers continue to adopt its systems because they see economic and outcome benefits. He described the total cost to treat per patient episode for a well-run program as “outstanding,” adding that hospitals achieve better outcomes, higher satisfaction, and the lowest total cost of care. He closed by reiterating the company’s belief in a “substantial and durable opportunity” to improve surgery and acute interventions, and its vision of care that is less invasive, with earlier disease identification and quicker treatment.